{"nctId":"NCT00421343","briefTitle":"Secondary Prevention of Osteoporosis","startDateStruct":{"date":"2007-02"},"conditions":["Osteoporosis"],"count":29,"armGroups":[{"label":"Treatment for osteoporosis and falls","type":"OTHER","interventionNames":["Drug: alendronate with cholecalciferol","Drug: calcium carbonate with cholecalciferol","Behavioral: Falls prevention measures"]}],"interventions":[{"name":"alendronate with cholecalciferol","otherNames":["Fosamax Plus DÂ®"]},{"name":"calcium carbonate with cholecalciferol","otherNames":["Os-Cal with extra D"]},{"name":"Falls prevention measures","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Admitted to rehab unit with the primary or secondary diagnosis of fracture\n* English speaking\n* Cognitively able to provide consent or health care proxy available and willing to provide consent\n* Willing to cooperate\n\nExclusion Criteria:\n\n* Pathologic or periprosthetic fractures\n* Creatinine clearance less than 15ml/minute\n* Severe hypocalcemia\n* Esophageal stricture or achalasia\n* Taking other treatment for osteoporosis besides calcium or vitamin D in the past 6-months\n* History of kidney stones in the past 6-months","healthyVolunteers":false,"sex":"ALL","minimumAge":"65 Years","stdAges":["OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number Adherent With the Intervention","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null}]}]}]},{"type":"SECONDARY","title":"Reasons for Non-willingness to Particiapte and Non-adherence With Intervention","description":"We asked participants who would not participate the primary reason for non-particiaption. We also asked participants who were not adherent with recommendations what the primary reason ws for non-adherence.","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":29},"commonTop":[]}}}